These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11912164

  • 21. Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer.
    Cozzi PJ, Wang J, Delprado W, Madigan MC, Fairy S, Russell PJ, Li Y.
    Hum Pathol; 2006 Nov; 37(11):1442-51. PubMed ID: 16949925
    [Abstract] [Full Text] [Related]

  • 22. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 23. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [Abstract] [Full Text] [Related]

  • 24. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
    Ellingsen C, Ovrebø KM, Galappathi K, Mathiesen B, Rofstad EK.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1317-23. PubMed ID: 22270159
    [Abstract] [Full Text] [Related]

  • 25. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
    Shariat SF, Roehrborn CG, McConnell JD, Park S, Alam N, Wheeler TM, Slawin KM.
    J Clin Oncol; 2007 Feb 01; 25(4):349-55. PubMed ID: 17264329
    [Abstract] [Full Text] [Related]

  • 26. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM, Ellingsen C, Galappathi K, Rofstad EK.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):e121-7. PubMed ID: 22381901
    [Abstract] [Full Text] [Related]

  • 27. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B.
    Gynecol Oncol; 2006 Apr 01; 101(1):28-39. PubMed ID: 16263158
    [Abstract] [Full Text] [Related]

  • 28. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination.
    Kobayashi H, Yagyu T, Kondo T, Kurita N, Inagaki K, Haruta S, Kawaguchi R, Kitanaka T, Sakamoto Y, Yamada Y, Kanayama N, Terao T.
    Cancer Res; 2005 Nov 15; 65(22):10464-71. PubMed ID: 16288038
    [Abstract] [Full Text] [Related]

  • 29. Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1.
    Jamaluddin MS.
    Biochem Biophys Res Commun; 2006 Sep 22; 348(2):618-27. PubMed ID: 16893520
    [Abstract] [Full Text] [Related]

  • 30. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X.
    Clin Cancer Res; 2007 Jun 01; 13(11):3115-24. PubMed ID: 17545513
    [Abstract] [Full Text] [Related]

  • 31. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2005 Sep 01; 14(3):777-82. PubMed ID: 16077991
    [Abstract] [Full Text] [Related]

  • 32. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
    Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL, Adler-Storthz K, Chen Z.
    Cancer; 2002 Oct 15; 95(8):1663-72. PubMed ID: 12365014
    [Abstract] [Full Text] [Related]

  • 33. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG.
    J Cell Physiol; 2005 Jul 15; 204(1):73-82. PubMed ID: 15573379
    [Abstract] [Full Text] [Related]

  • 34. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
    Saldanha RG, Xu N, Molloy MP, Veal DA, Baker MS.
    J Proteome Res; 2008 Nov 15; 7(11):4792-806. PubMed ID: 18808175
    [Abstract] [Full Text] [Related]

  • 35. The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model.
    Fisher JL, Mackie PS, Howard ML, Zhou H, Choong PF.
    Clin Cancer Res; 2001 Jun 15; 7(6):1654-60. PubMed ID: 11410503
    [Abstract] [Full Text] [Related]

  • 36. uPA receptor expression in benign and malignant thyroid tumors.
    Kim SJ, Shiba E, Taguchi T, Tsukamoto F, Miyoshi Y, Tanji Y, Takai S, Noguchi S.
    Anticancer Res; 2002 Jun 15; 22(1A):387-93. PubMed ID: 12017319
    [Abstract] [Full Text] [Related]

  • 37. Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma.
    Wang J, Guo F, Wei H, Dong J, Wu J.
    Br J Oral Maxillofac Surg; 2006 Dec 15; 44(6):515-9. PubMed ID: 16356605
    [Abstract] [Full Text] [Related]

  • 38. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.
    Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645
    [Abstract] [Full Text] [Related]

  • 39. Expression of urokinase-type plasminogen activator and its receptor is up-regulated during tendon healing.
    Xia W, de Bock C, Murrell GA, Wang Y.
    J Orthop Res; 2003 Sep 01; 21(5):819-25. PubMed ID: 12919869
    [Abstract] [Full Text] [Related]

  • 40. [The expression of urokinase-type plasminogen activator and its receptor in urinary transitional cell carcinoma].
    Li YJ, Zheng BZ, Zhou ZL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan 01; 35(1):57-9. PubMed ID: 14981816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.